Search research articles
Contact Us
Filters
Showing results (31-40 of 48) with videos related to
Page
of 5
Sort By:
Cancer Discovery
|
May 3, 2020
Case Fatality Rate of Cancer Patients with COVID-19 in a New York Hospital System
Vikas Mehta, Sanjay Goel, Rafi Kabarriti, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
April 14, 2019
Distinctive mechanisms underlie the loss of SMARCB1 protein expression in renal medullary carcinoma: morphologic and molecular analysis of 20 cases
Liwei Jia, Maria I Carlo, Hina Khan, et al.
The Journal of Clinical Investigation
|
April 23, 2024
Renal cell carcinoma histologic subtypes exhibit distinct transcriptional profiles
Pedro Barata, Shuchi Gulati, Andrew Elliott, et al.
British Journal of Cancer
|
November 11, 2023
Apalutamide efficacy, safety and wellbeing in older patients with advanced prostate cancer from Phase 3 randomised clinical studies TITAN and SPARTAN
John Shen, Simon Chowdhury, Neeraj Agarwal, et al.
JNCI Cancer Spectrum
|
June 3, 2022
The Impact of Androgen Deprivation Therapy on COVID-19 Illness in Men With Prostate Cancer
Neil J Shah, Vaibhav G Patel, Xiaobo Zhong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 16, 2022
Telaglenastat plus Everolimus in Advanced Renal Cell Carcinoma: A Randomized, Double-Blinded, Placebo-Controlled, Phase II ENTRATA Trial
Chung-Han Lee, Robert Motzer, Hamid Emamekhoo, et al.
Hypertension (Dallas, Tex. : 1979)
|
May 20, 2026
Cluster Randomized Trial of Intensive Systolic Blood Pressure Control in Patients With Renal Cell or Thyroid Cancer Receiving VEGFR Tyrosine Kinase Inhibitors: ECOG-ACRIN EAQ191
Bonnie Ky, Tao Liu, Kenneth B Margulies, et al.
Clinical Genitourinary Cancer
|
August 8, 2021
A Prospective Multicenter Evaluation of Initial Treatment Choice in Metastatic Renal Cell Carcinoma Prior to the Immunotherapy Era: The MaRCC Registry Experience
Brian A Costello, Nrupen A Bhavsar, Yousef Zakharia, et al.
Cancer
|
March 25, 2021
Active surveillance of metastatic renal cell carcinoma: Results from a prospective observational study (MaRCC)
Michael R Harrison, Brian A Costello, Nrupen A Bhavsar, et al.
The Journal of Urology
|
January 24, 2020
Histological Subtypes and Response to PD-1/PD-L1 Blockade in Advanced Urothelial Cancer: A Retrospective Study
Natalie J Miller, Ali Raza Khaki, Leonidas N Diamantopoulos, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 48) with videos related to
Sort By:
Page
of 5
Cancer Discovery
|
May 3, 2020
Case Fatality Rate of Cancer Patients with COVID-19 in a New York Hospital System
Vikas Mehta, Sanjay Goel, Rafi Kabarriti, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
April 14, 2019
Distinctive mechanisms underlie the loss of SMARCB1 protein expression in renal medullary carcinoma: morphologic and molecular analysis of 20 cases
Liwei Jia, Maria I Carlo, Hina Khan, et al.
The Journal of Clinical Investigation
|
April 23, 2024
Renal cell carcinoma histologic subtypes exhibit distinct transcriptional profiles
Pedro Barata, Shuchi Gulati, Andrew Elliott, et al.
British Journal of Cancer
|
November 11, 2023
Apalutamide efficacy, safety and wellbeing in older patients with advanced prostate cancer from Phase 3 randomised clinical studies TITAN and SPARTAN
John Shen, Simon Chowdhury, Neeraj Agarwal, et al.
JNCI Cancer Spectrum
|
June 3, 2022
The Impact of Androgen Deprivation Therapy on COVID-19 Illness in Men With Prostate Cancer
Neil J Shah, Vaibhav G Patel, Xiaobo Zhong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 16, 2022
Telaglenastat plus Everolimus in Advanced Renal Cell Carcinoma: A Randomized, Double-Blinded, Placebo-Controlled, Phase II ENTRATA Trial
Chung-Han Lee, Robert Motzer, Hamid Emamekhoo, et al.
Hypertension (Dallas, Tex. : 1979)
|
May 20, 2026
Cluster Randomized Trial of Intensive Systolic Blood Pressure Control in Patients With Renal Cell or Thyroid Cancer Receiving VEGFR Tyrosine Kinase Inhibitors: ECOG-ACRIN EAQ191
Bonnie Ky, Tao Liu, Kenneth B Margulies, et al.
Clinical Genitourinary Cancer
|
August 8, 2021
A Prospective Multicenter Evaluation of Initial Treatment Choice in Metastatic Renal Cell Carcinoma Prior to the Immunotherapy Era: The MaRCC Registry Experience
Brian A Costello, Nrupen A Bhavsar, Yousef Zakharia, et al.
Cancer
|
March 25, 2021
Active surveillance of metastatic renal cell carcinoma: Results from a prospective observational study (MaRCC)
Michael R Harrison, Brian A Costello, Nrupen A Bhavsar, et al.
The Journal of Urology
|
January 24, 2020
Histological Subtypes and Response to PD-1/PD-L1 Blockade in Advanced Urothelial Cancer: A Retrospective Study
Natalie J Miller, Ali Raza Khaki, Leonidas N Diamantopoulos, et al.
Page
of 5